The India Fund, Inc. (IFN) |
|
17.9 0.41 (2.34%)
|
05-18 02:12 |
|
Open: |
17.8 |
Pre. Close: |
17.49 |
|
High:
|
17.93 |
Low:
|
17.68 |
|
Volume:
|
103,202 |
Market Cap:
|
489(M) |
|
|
|
|
The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
17.96 - 18.03 |
18.03 - 18.1 |
|
Low:
|
17.5 - 17.58 |
17.58 - 17.65 |
|
Close:
|
17.78 - 17.91 |
17.91 - 18.04 |
|
Technical analysis |
as of: 2022-05-17 4:47:52 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 21.42  One year: 22.76 |
| Support: |
Support1: 16.48 Support2: 13.71 |
| Resistance: |
Resistance1: 18.34 Resistance2: 19.48 |
| Pivot: |
17.62 |
| Moving Average: |
MA(5): 17.16  MA(20): 17.87
MA(100): 19.67 MA(250): 21.34 |
| MACD: |
MACD(12,26): -0.5 Signal(9): -0.6 |
| Stochastic oscillator: |
%K(14,3): 48 %D(3): 28.7 |
| RSI: |
RSI(14): 47.7 |
| 52-week: |
High: 23.78 Low: 16.48 |
| Average Vol(K): |
3-Month: 118 (K) 10-Days: 133 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IFN ] has closed below upper band by 38.8%. Bollinger Bands are 29.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 17 May 2022
Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes - News-Medical.Net
Tue, 17 May 2022
Camelid IFNs could play important role in combating emerging zoonotic pathogens - News-Medical.Net
Tue, 17 May 2022
Type-I interferon stops immune system 'going rogue' during viral infections - Science Daily
Tue, 17 May 2022
Lymph node colonization and metastasis - Science
Tue, 17 May 2022
Inhaled Interferon Fails in Pivotal COVID Trial, but Developer Pushes On - Medpage Today
Mon, 16 May 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies - pnas.org
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Financial Services |
| Industry: Asset Management |
| Shares Out. |
0 (M) |
| Shares Float |
27 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
21 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
3 |
|
Operating Margin (%)
|
164 |
|
Return on Assets (ttm)
|
-17.2 |
|
Return on Equity (ttm)
|
-0.2 |
|
Qtrly Rev. Growth
|
6.84e+006 |
|
Gross Profit (p.s.)
|
17.46 |
|
Sales Per Share
|
49.11 |
|
EBITDA (p.s.)
|
8.20253e+006 |
|
Qtrly Earnings Growth
|
8 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0.36 |
|
Price to Cash Flow
|
0.59 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
16940 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-01-09 |
|
Ex-Dividend Date
|
2021-12-28 |
|
7 Binary Options
|
|
Your Ad Here
|
|
